NCT00239915View on ClinicalTrials.gov

Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2006

Conditions
Persistent Developmental Stuttering
Interventions
DRUG

Pagoclone

Trial Locations (1)

92506

Pharmacology Research Institute, Riverside

Sponsors
All Listed Sponsors
lead

Pharmacology Research Institute

OTHER